1 Min Read
June 12 (Reuters) - IMMUNICUM AB
* IMMUNICUM AB (PUBL) ANNOUNCES APPROVAL OF THE INTERNATIONAL NONPROPRIETARY NAME (INN) ILIXADENCEL FOR INTUVAX® Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.